Affinity Asset Advisors’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
KCM
Affinity Asset Advisors's BEAM Position: Q3 2026 in Review
Affinity Asset Advisors opened a new position in Beam Therapeutics (BEAM) in Q3 2026: 450,000 shares worth $11M. The stake represents 0.45% of the portfolio and ranks #51 among its holdings.
260 funds tracked by Wall St. Rank hold BEAM as of Q3 2026.
- Affinity Asset Advisors held 450,000 shares of Beam Therapeutics worth $11M as of Q3 2026.
- Beam Therapeutics was a new Affinity Asset Advisors position in Q3 2026.
- Beam Therapeutics made up 0.45% of Affinity Asset Advisors's portfolio in Q3 2026, its #51 holding.
- 260 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2026.
Based on Affinity Asset Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.